Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

421 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 421 results

Not applicableStudy completedNCT05022758
What this trial is testing

Learn Whether There Are Differences in the Kidney's Ability to Work Properly in Korean Patients With Non-valvular Atrial Fibrillation (Irregular and Often Rapid Heartbeat Not Caused by a Heart Valve Problem) Treated With Rivaroxaban as Compared to Those Treated With Warfarin

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 45,000
Not applicableLooking for participantsNCT02219984
What this trial is testing

START-Register: Survey on Anticoagulated Patients Register

Who this might be right for
Atrial FibrillationVenous ThromboembolismHeart Valve Diseases or Prosthesis
GUALTIERO PALARETI 15,410
Post-approval studies (Phase 4)UnknownNCT05210725
What this trial is testing

Trained Immunity by Dual-pathway Inhibition in Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
Radboud University Medical Center 20
Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Not applicableStudy completedNCT01750788
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia

Who this might be right for
Atrial Fibrillation
Bayer 2,297
Not applicableUnknownNCT05658042
What this trial is testing

Dose Optimization of Rivaroxaban Combined With Rifampicin

Who this might be right for
Infections
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 80
Large-scale testing (Phase 3)Study completedNCT03181386
What this trial is testing

Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants

Who this might be right for
Atrial FibrillationPeriodontal DiseaseHemorrhage
University of Sao Paulo General Hospital 60
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Post-approval studies (Phase 4)Not Yet RecruitingNCT05487950
What this trial is testing

Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk

Who this might be right for
Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
Assistance Publique - Hôpitaux de Paris 550
Not applicableStudy completedNCT06184204
What this trial is testing

Observational Study:Safety,Efficacy and Quality of Life of Patients With Atrial Fibrillation, Treated With Trombix®

Who this might be right for
Atrial Fibrillation
Beker Laboratories 398
Not applicableStudy completedNCT00831714
What this trial is testing

Xarelto for VTE Prophylaxis After Hip or Knee Arthroplasty

Who this might be right for
Venous Thromboembolism
Bayer 19,076
Testing effectiveness (Phase 2)Study completedNCT00398905
What this trial is testing

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Who this might be right for
Venous Thromboembolism
Bayer 726
Post-approval studies (Phase 4)UnknownNCT04169269
What this trial is testing

Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban

Who this might be right for
Deep Vein ThrombosisVenous Thromboembolism
Florida Orthopaedic Institute 128
Large-scale testing (Phase 3)Study completedNCT00809965
What this trial is testing

An Efficacy and Safety Study for Rivaroxaban in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionMyocardial Ischemia+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 15,526
Not applicableStudy completedNCT02210819
What this trial is testing

Treatment of Venous Thromboembolism (VTE) With Either Rivaroxaban or Current Standard of Care Therapy

Who this might be right for
Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)
Bayer 1,987
Testing effectiveness (Phase 2)Study completedNCT01442792
What this trial is testing

Exploring the Efficacy and Safety of Rivaroxaban to Support Elective Percutaneous Coronary Intervention

Who this might be right for
Cardiovascular DiseaseCoronary Artery Disease
Bayer 108
Large-scale testing (Phase 3)Study completedNCT01431456
What this trial is testing

Safety of DAbigatran and RIvaroxaban Versus NAdroparin in the Prevention of Venous Thromboembolism After Knee Arthroplasty Surgery

Who this might be right for
Venous Thromboembolism
Martini Hospital Groningen 148
Not applicableStudy completedNCT04505475
What this trial is testing

Oral Surgery in Patients Taking Direct Oral Anticoagulants

Who this might be right for
Anticoagulants and Bleeding DisordersSurgeryPostoperative Hemorrhage+1 more
University of Novi Sad 82
Large-scale testing (Phase 3)Looking for participantsNCT04066764
What this trial is testing

Rivaroxaban and Vitamin K Antagonists for the Anticoagulation for the Implantation of Vena Cava Filters

Who this might be right for
Venous Thromboembolism
Second Affiliated Hospital, School of Medicine, Zhejiang University 200
Load More Results